Jefferies Group’s Array Biopharma Inc ARRY Stock Holding History

Jefferies Group’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-167,500	Closed	-$7.76M	–	3248
2019 Q2	$7.76M	Buy	+167,500	New	+$4.7M	0.06%	294
2017 Q3	–	Sell	-128,600	Closed	-$1.08M	–	2738
2017 Q2	$1.08M	Buy	128,600 +200	+0.2%	+$1.64K	0.01%	1261
2017 Q1	$1.15M	Buy	+128,400	New	+$1.37M	0.01%	1201
2016 Q1	–	Sell	-4,800	Closed	-$20K	–	2729
2015 Q4	$20K	Buy	+4,800	New	+$21.9K	﹤0.01%	2181

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Jefferies Group's ARRY Position: Q3 2019 in Review

Jefferies Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 80,696 shares — an estimated $3.74M sold.

Jefferies Group first reported a position in ARRY in Q2 2013 and held it in 8 quarters. The position peaked at $3.74M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Jefferies Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Jefferies Group sold 80,696 Array Biopharma Inc shares in Q3 2019, an estimated $3.74M.
Jefferies Group first reported a position in Array Biopharma Inc in Q2 2013 and held it in 8 quarters.
Jefferies Group's Array Biopharma Inc position peaked at $3.74M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.